Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Exact Sciences Cor (NQ: EXAS )

47.99 +1.18 (+2.53%)
Streaming Delayed Price Updated: 12:24 PM EDT, Jul 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Exact Sciences Cor

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Toro Posts Upbeat Results, Joins Clear Channel Outdoor, Marathon Digital And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded mixed, with the Dow Jones index falling around 50 points on Wednesday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Is This BioTech Play Severely Undervalued? BioTech Shares Promising Results From Colorectal Study
Via Benzinga
1 Supercharged Growth Stock to Buy Before It Soars as Much as 222%, According to Cathie Wood's Ark Invest
If the fund manager's calculations prove to be correct, shareholders could enjoy threefold returns over the coming four years. Is she right? 
Via The Motley Fool
5 Analysts Have This to Say About Exact Sciences
Via Benzinga
Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week
S&P 500 earnings is expected to grow in Q3, reversing a four-quarter slide, as the reporting season enters its third week. 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Analyst Ratings for Exact Sciences
Via Benzinga
Better Growth Stock: Vertex Pharmaceuticals or Exact Sciences?
Both of these biotech stocks have been market-beaters over the prior 10 years. One stock, however, is a better buy right now. 
Via The Motley Fool
3 Stocks at the Forefront of Personalized Medicine Trend
Unveiling the impact of personalized medicine stocks, transforming patient care, and propelling market growth seamlessly 
Via InvestorPlace
A Bull Market Is Coming: 1 Incredible Growth Stock to Buy Hand Over Fist Before It Soars 729%, According to Cathie Wood's Ark Invest
If the fund manager's calculations prove to be correct, Tesla shareholders could enjoy sevenfold returns over the coming four years. Is she right? 
Via The Motley Fool
The 3 Best Digital Health Stocks for Personalized Medicine
Digital health stocks are becoming increasingly relevant as more and more people seek greater control over their health. 
Via InvestorPlace
Cathie Wood's Ark Invest Buys $12.6M Of Zoom Shares Following Positive Earnings
Via Benzinga
3 Biotech Stocks With Big-Time Breakthrough Potential
The biotech industry is filled with opportunity with these sure winners, pick up high-potential stocks like these and ride the wave. 
Via InvestorPlace
2 Revolutionary Stocks That Could Turn $1,000 Into $2,000 by 2030
Don't miss out on these potentially market-beating stocks. 
Via The Motley Fool
Exact Sciences Sues Rival Geneoscopy Related To Colon Cancer Test Cologuard Patent
Exact Sciences Corp (NASDAQ: EXAS) filed a patent infringement lawsuit against Geneoscopy in the U.S. 
Via Benzinga
Topics Intellectual Property Lawsuit
Exposures Financial Intellectual Property Legal
3 Stocks to Love Despite All of the Wall Street Hate
We're in the early stages of a bull market, so the Street hates most smaller companies, but these contrarian stock picks are set to soar. 
Via InvestorPlace
7 Biotech Stocks to Buy for Big-Time Gains
Biotech stocks can be big winners because they're at the forefront of scientific innovation and push the boundaries of medical research. 
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Exact Sciences (EXAS) Q3 2023 Earnings Call Transcript
EXAS earnings call for the period ending September 30, 2023. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Exact Sciences, A Cathie Wood Holding, Comes In Hot With Double-Digit Sales Growth
The company makes a diagnostic tool to detect colon cancer. 
Via Investor's Business Daily
Nasdaq, S&P 500 Futures Slide Ahead Of Fed Decision, Economic Data: Analyst Tells Why November Could Herald 'Good News'
U.S. stocks could start Wednesday's session lower as traders stay cautious ahead of the Fed decision and more earnings. 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Jim Cramer Wants You To 'Stay Away' From This Energy Corporation: 'I've Got So Many Other Good Oil Companies'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said CVS Health Corporation (NYSE: CVS) is a retailer that has a healthcare business. "It’s not a healthcare business that is a retailer, and retail... 
Via Benzinga
Cathie Wood's Ark Invest Sells $1.9M in Grayscale Bitcoin Fund, Sheds Coinbase Holdings And Shops For $1.8M Worth Of Robinhood Stock
On Tuesday, Cathie Wood-led Ark Invest made significant trades, with a notable purchase of shares in Robinhood Markets Inc (NASDAQ:HOOD) while offloading positions in Coinbase Global Inc (NASDAQ:COIN)... 
Via Benzinga
3 Comeback Stocks to Buy Before They Soar Again in 2024
High Treasury yields were triggered by economic growth, not inflation. As a result, there are likely to be many comeback stocks. 
Via InvestorPlace
Topics Economy
Exposures Interest Rates
Cathie Wood's Biggest Holdings Are Tumbling, Including Tesla
Even Ark Invest's big 2023 winners are well off highs. 
Via Investor's Business Daily
7 Winning Stocks That Will Make You an Investing Champion
Inflation is under control and economic growth is strong. Here are seven winning stocks to buy to exploit the positive trends. 
Via InvestorPlace
Topics Economy
Exposures Interest Rates
Cathie Wood’s 3 Favorite AI Stocks: October 2023
Despite the surprising sale of her Nvidia stock, investors can still look to Cathie Wood for guidance on future purchases of AI stocks. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
7 Affordable Stocks to Invest in as America’s Population Ages
Stocks for an aging population include some surprisingly youthful products and firms not commonly associated with seniors. 
Via InvestorPlace
Exact Sciences' Stock Offers A 'Good Entry Point,' This Bullish Analyst Says
Shares of Exact Sciences Corp (NASDAQ: EXAS) were climbing in early trading on Tuesday, ahead of the company’s third-quarter earnings call. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2023
Via Benzinga
Which Is the Better Cancer-Testing Healthcare Stock: Exact Sciences or Guardant Health?
The oncology diagnostic companies are looking for better solutions in early cancer diagnosis. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.